ClinicalTrials.Veeva

Menu

Changes in Cerebral Oxygenation and Cognitive Functions

Z

Zonguldak Bulent Ecevit University

Status

Completed

Conditions

Hypotension; Controlled
Cognitive Dysfunction

Treatments

Drug: Nitroglycerin
Drug: Esmolol

Study type

Observational

Funder types

Other

Identifiers

NCT04948957
2013-81-03/09

Details and patient eligibility

About

The present study aimed to assess the influence of nitroglycerin and esmolol-induced hypotension on cerebral oxygen saturation by using near-infrared spectroscopy and postoperative cognitive function in patients undergoing nasal surgery.

Enrollment

40 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • written informed consent
  • patients with ASA physical status of I-II
  • aged 18-65 years

Exclusion criteria

  • Age under 18 or above 65
  • ASA > II
  • coagulation disorders
  • history of cardiovascular and cerebrovascular disease
  • poor Blood Pressure control
  • anemia, pregnancy, addiction to opioids
  • body mass index (BMI) > 35
  • intraoperative systolic BP < 65 mmHg
  • surgical duration less than 30 minutes or more than 160 minutes
  • need for an intraoperative sympathomimetic drug and the use of other hypotensive drugs
  • preoperative Mini-Mental State Examination (MMSE) score of 23 or less.

Trial design

40 participants in 2 patient groups

esmolol (Group E)
Treatment:
Drug: Esmolol
nitroglycerin (Group N)
Treatment:
Drug: Nitroglycerin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems